Similarly, C5orf38 had a significant mediation effect of 65.6% on CRC outcomes through cholesterol-to-total-lipids ratio in IDL, as well as a 24.6% effect through PFA. This evidence concerns the gene IRX2-DT and colorectal carcinoma.